Advances in Radiation Oncology
Scope & Guideline
Transforming Research into Radiotherapy Innovations
Introduction
Aims and Scopes
- Clinical and Dosimetric Studies:
The journal consistently publishes research that evaluates clinical outcomes and dosimetric parameters in various cancer treatments, including comparisons between different radiation therapy techniques (e.g., IMRT, proton therapy) and their impacts on patient health. - Innovative Radiation Therapy Techniques:
There is a strong emphasis on innovative approaches such as stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), and the use of advanced imaging techniques (e.g., MRI-guided therapy) to enhance treatment precision and efficacy. - Integration of Technology in Radiation Oncology:
The journal explores the integration of new technologies, including artificial intelligence (AI), machine learning, and automated treatment planning systems, to streamline processes and improve treatment delivery. - Multidisciplinary Approaches in Cancer Treatment:
Publications often address the collaboration between various specialties, including the integration of systemic therapies, surgical interventions, and palliative care alongside radiation therapy. - Patient-Centered Care and Quality of Life:
Research focusing on patient-reported outcomes, managing treatment-related toxicities, and improving overall quality of life for patients undergoing radiation therapy is a recurring theme.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a growing body of research focusing on the application of AI and machine learning in radiation oncology, particularly in treatment planning, patient stratification, and predictive modeling of treatment outcomes. - Hypofractionated and Ultra-Hypofractionated Therapies:
An increase in studies exploring hypofractionation and ultra-hypofractionation techniques indicates a shift towards more efficient treatment regimens that aim to reduce treatment time while maintaining efficacy. - Patient Experience and Quality of Life Assessments:
Emerging research increasingly emphasizes the importance of patient-reported outcomes and quality of life assessments, reflecting a trend towards more holistic and patient-centered approaches in cancer care. - Combination Therapies with Immunotherapy:
The integration of radiation therapy with immunotherapy is gaining traction, with numerous studies exploring how these modalities can synergize to improve patient outcomes in various cancer types. - Telemedicine and Remote Care Models:
The rise of telemedicine, particularly accelerated by the COVID-19 pandemic, is a new area of focus, with research aimed at understanding its effectiveness and patient acceptance in the context of radiation oncology.
Declining or Waning
- Traditional Fractionation Schedules:
There appears to be a waning interest in traditional fractionation schedules as the field shifts towards hypofractionation and more personalized treatment regimens that optimize patient outcomes. - Conventional Imaging Techniques:
Research centered around conventional imaging methods is decreasing, likely due to advancements in imaging technologies such as MRI and PET that provide more detailed insights into tumor behavior and treatment response. - General Population Studies:
Studies focusing on broad population-level analyses without specific interventions or targeted assessments are becoming less frequent, as there is a stronger push for precision medicine and individualized treatment approaches. - Basic Research on Radiation Biology:
While foundational research remains important, there has been a notable decline in publications dedicated solely to the basic biology of radiation effects, as more emphasis is placed on clinical applications and outcomes. - Single-Institution Studies:
There seems to be a shift away from single-institution studies towards multi-institutional collaborations that provide broader applicability and generalizability of findings.
Similar Journals
Radiological Physics and Technology
Elevating standards in radiation sciences.Radiological Physics and Technology, published by SPRINGER JAPAN KK, is a prominent journal that serves as a crucial resource in the multidisciplinary fields of medicine and radiation sciences. With an ISSN of 1865-0333 and an E-ISSN of 1865-0341, the journal has been converging impactful research from 2008 to 2024. It holds a commendable position in academic rankings, currently classified in Q2 in Physical Therapy, Sports Therapy and Rehabilitation and Radiation, along with Q3 for Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging. The journal is well-regarded in the academic community, reflected in its Scopus rankings that place it in the upper tiers of its respective categories. Although it currently does not offer Open Access, Radiological Physics and Technology remains a pivotal publication for researchers, academics, and practitioners seeking to advance knowledge and foster innovation in radiological science. Its commitment to disseminating high-quality research ensures its continued relevance and importance within these fields.
MEDICAL PHYSICS
Championing Excellence in Medical Physics ScholarshipMEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.
Brachytherapy
Exploring Cutting-Edge Techniques in Oncology and Radiology.Brachytherapy, published by ELSEVIER SCIENCE INC, serves as a pivotal journal in the realms of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1538-4721 and an E-ISSN of 1873-1449, the journal disseminates cutting-edge research and advancements from 2002 to 2024, focusing on the innovative field of brachytherapy. Although classified in the Q3 category for Oncology and Q2 for Radiology, Nuclear Medicine, and Imaging based on the 2023 quartile rankings, it continues to make significant contributions to clinical practice and methodology. Brachytherapy holds a respectable position in Scopus, ranking #155/333 and #234/404 in its respective categories, which reflects its importance and relevance to the scientific community. This journal is indispensable for researchers, healthcare professionals, and students looking to stay abreast of the latest techniques and therapeutic approaches in cancer treatment and imaging practices.
PROSTATE CANCER AND PROSTATIC DISEASES
Elevating standards in prostate disease management.PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.
Journal of Medical Imaging and Radiation Oncology
Innovating Imaging Techniques for a Healthier TomorrowJournal of Medical Imaging and Radiation Oncology, published by WILEY, is a pivotal resource in the fields of oncology and medical imaging. With an impact factor reflective of its commitment to advancing research, the journal has maintained a robust reputation since its inception in 2008 and continues to thrive through 2024. It is indexed with an insightful ranking, with a Q2 classification in Radiology, Nuclear Medicine and Imaging, affirming its importance in these disciplines. This journal not only serves as an open access platform, allowing extensive reach and accessibility, but also fosters a scholarly community dedicated to the innovation of imaging techniques and radiation oncology practices. As a key player in disseminating crucial findings and advancements, it appeals to researchers, clinicians, and students who aim to contribute to the evolving landscape of medical imaging and cancer treatment methodologies. The journal is based in Australia, at 111 River St, Hoboken, NJ, and invites submissions that push the boundaries of current knowledge in this critical area of healthcare.
Radiation Oncology
Advancing cancer care through innovative radiotherapy insights.Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.
STRAHLENTHERAPIE UND ONKOLOGIE
Empowering professionals with cutting-edge insights.STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.
PHYSICS IN MEDICINE AND BIOLOGY
Merging Physics with Medicine for a Healthier FuturePHYSICS IN MEDICINE AND BIOLOGY is a prestigious journal published by IOP Publishing Ltd, with a storied history dating back to 1956 and extending through 2024. This internationally recognized journal caters to the interdisciplinary fields of medical physics and bioengineering, making significant contributions to the research and development of advanced diagnostic and therapeutic technologies. It holds an impressive Q1 ranking in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine and Imaging categories, reflecting its critical role in disseminating high-quality research. With a significant focus on merging the principles of physics with advancements in medicine, PHYSICS IN MEDICINE AND BIOLOGY serves as an essential resource for researchers, professionals, and students alike, fostering innovation and enhancing collaboration in the healthcare sector. Although the journal is not currently open access, it maintains robust participation in the Scopus database, ranking #62 out of 333 in Radiology, Nuclear Medicine and Imaging and #17 out of 63 in Radiological and Ultrasound Technology, signifying its influence and reach within these disciplines.
Journal of the Egyptian National Cancer Institute
Empowering oncology insights through open access.Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.
ACTA ONCOLOGICA
Elevating standards in oncology research and practice.ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.